Sermorelin Before and After Results and What Trials Measured

Search results for sermorelin before and after are full of smiling faces and tidy timelines. This case tests the claim that sermorelin produces visible changes in face, body and mood. A photo is a weak form of evidence, so we looked for the measurements behind the pictures instead. Sermorelin is a short piece of growth hormone releasing hormone. It was once an approved children's drug, and the adult trials were small. Here is what they measured and what they did not.

Why Sermorelin Photos Prove Little

A before and after photo records one moment and one set of conditions. Light, angle, weight, tan, sleep, diet and a second treatment can all change a face in a few weeks. Nothing in a photo shows which of them did the work, and nobody sees the people whose pictures were never posted. Search for sermorelin before and after pictures and you will find collections chosen by sellers and clinics, who benefit when the answer is yes. A trial answers a different question. It compares a treated group with a placebo group and measures the same thing in everyone, so the changes can be traced to the treatment and not to the photographer.

That difference matters most for faces. People usually cannot judge their own change reliably, and expectation shifts what they see. In a blinded trial, raters who do not know who was treated score photos against a fixed scale. We found no such trial for sermorelin. The sermorelin peptide before and after claim therefore rests on anecdote, and a before and after sermorelin story is still a single case. It is not worthless, because it can suggest a question. It cannot answer one, and it cannot be graded by size, risk or repeatability, which is what a reader needs before spending money or accepting a risk.

What Geref Was Approved to Do

Sermorelin acetate was sold in the United States as Geref by EMD Serono. FDA's 2013 Federal Register notice says the vial form was indicated for idiopathic growth hormone deficiency in children with growth failure, and a smaller ampule was approved to test whether the pituitary can secrete growth hormone. The company told FDA in 2008 that it was discontinuing both, and FDA withdrew the approvals effective June 18, 2009. After a citizen petition, FDA found in 2013 that the products were not withdrawn for reasons of safety or effectiveness. That was a legal finding about generic applications, not a new endorsement.

The history is often used as a selling point, and it needs care. Approval for children with a diagnosed hormone deficiency says little about healthy adults who want a younger look. The Geref approvals are gone and we found no approved sermorelin product on the market, so a product sold today is a compounded or unlicensed preparation. A 2026 review of growth hormone axis peptides notes that the benefits in healthy people remain uncertain, with limited and mostly indirect evidence, and that unregulated supply chains carry quality and composition problems. WADA also lists sermorelin among prohibited growth hormone releasing hormone analogues, so tested athletes cannot use it.

What Trials in Older Adults Measured

Two 1997 studies are cited most often. Vittone and colleagues followed healthy men aged 64 to 76 with low IGF-I during six weeks of nightly self injection of GHRH 1-29. Night time growth hormone release rose, but IGF-I did not, and weight, body composition and muscle structure were unchanged. A few strength and endurance tests improved, and no significant side effects were seen. The abstract describes no control group. Khorram and colleagues ran a single blind, placebo controlled trial in 19 people aged 55 to 71, using a close analogue of GHRH 1-29 for 16 weeks. Growth hormone and IGF-I rose.

Face Skin Women and Men Claims Checked

Skin is the most sensitive test of the face claim. In the Khorram trial, skin thickness measured with calipers rose in both sexes. That is a real measurement, but it is not the same as fewer wrinkles, better tone or a younger look, and the authors did not claim it was. Searches for skin sermorelin before and after or sermorelin before and after face turned up no controlled trial that graded appearance. Growth hormone can raise skin thickness through fluid and tissue changes, so a thicker measurement may come with swelling and not with a visibly younger face, which is why the caliper result stays a lab number.

Sex differences are the next question. Khorram reported that lean mass, insulin sensitivity, wellbeing and libido improved in men but not in women, which led the authors to say the effects favored men. Anyone reading sermorelin for females before and after stories, or sermorelin before and after women lists, should note that this trial did not show those gains in women. For sermorelin before and after male claims, the trial supports a small gain in lean mass in a small group, using an analogue and not the product sold today. Stories are not a substitute for a larger controlled trial.

Conclusion

Sermorelin before and after claims rest on photos and testimonials, while the controlled data are two small 1997 studies in older adults. They show more night time growth hormone, a thicker skin measurement and, in men, a small rise in lean mass. They do not show a visibly younger face. Verdict: weak. We give no dose or schedule, because none is established for unapproved use.